BERLIN—Bayer AG shares resumed their monthslong fall on Tuesday after the company was hit by a more-than $2 billion jury award over its Roundup herbicide, marking a sharp escalation in the chemical and drug giant’s legal woes. The shares were down 2.3% in Europe—one of the worst performers in the Frankfurt stock exchange’s blue-chip DAX index, which was trading up on the day—after hitting a seven-year low. The fall followed Bayer’s third Roundup court defeat in 10 months. A California jury on Monday awarded $2.055 billion...

Source: Wall Street Journal May 14, 2019 10:35 UTC